ArticleInvestigative ophthalmology & visual science2026
FLVCR2 Regulation of Intracellular Heme Modulates Vascular Tip/Stalk Specification During Retinal Angiogenesis.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Fowler syndrome is an embryonic lethal disease with proliferative vasculopathy and hydranencephaly-hydrocephaly of the central nervous system caused by mutations in feline leukemia virus subgroup C receptor-related protein 2 (FLVCR2) characterized by large regions of hypovascularization along with glomeruloid formation of poorly organized vascular endothelial cell masses. The purpose of the current study is to elucidate the mechanisms by which FLVCR2 regulates retinal angiogenesis. Methods: Recent animal models have characterized reduced brain vascularization in gene deletion models of Flvcr2. Here, we use conditional knockout of Flvcr2 in mice and knockdown in primary bovine retinal endothelial cell culture to explore retinal development and associated mechanisms of angiogenic regulation by FLVCR2. Results: Endothelial cell-specific deletion of Flvcr2 or chemical inhibition of heme synthesis during post-natal retinal vascularization led to reduced vascular expansion in both primary (superficial) and secondary (deep) vascular plexuses, and a more severe but partially penetrant phenotype with attenuation of retinal vascular development and formation of abnormal vascular glomeruloids. Mechanistically, Flvcr2 knockdown in retinal endothelial cells led to reduced heme content and promoted NOTCH signaling and hyperproliferation that could be reversed with addition of a heme precursor. Similar effects were observed in cells treated with inhibitors of heme synthesis and reversed with addition of cell-permeable hemin. Furthermore, we found that FLVCR2/heme signaling attenuates NOTCH1 activation and affects downstream tip/stalk cell specification, while also preventing VEGF-induced proliferation. Conclusions: Collectively, these data indicate a newly identified role for FLVCR2 and heme in the regulation of tip/stalk specification in angiogenesis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.